498 related articles for article (PubMed ID: 29249655)
21. EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer.
Kang J; Chun J; Hwang JS; Pan C; Li J; Boese AC; Young I; Malin CM; Kang Y; Gibbons DL; Sica G; Fu H; Ramalingam SS; Jin L; Kang S
Cell Rep; 2022 Dec; 41(11):111827. PubMed ID: 36516759
[TBL] [Abstract][Full Text] [Related]
22. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis.
Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG
Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879
[TBL] [Abstract][Full Text] [Related]
23. LKB1 regulated pathways in lung cancer invasion and metastasis.
Marcus AI; Zhou W
J Thorac Oncol; 2010 Dec; 5(12):1883-6. PubMed ID: 21102257
[TBL] [Abstract][Full Text] [Related]
24. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.
Carretero J; Medina PP; Blanco R; Smit L; Tang M; Roncador G; Maestre L; Conde E; Lopez-Rios F; Clevers HC; Sanchez-Cespedes M
Oncogene; 2007 Mar; 26(11):1616-25. PubMed ID: 16953221
[TBL] [Abstract][Full Text] [Related]
25. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
26. Fibronectin regulates anoikis resistance via cell aggregate formation.
Han HJ; Sung JY; Kim SH; Yun UJ; Kim H; Jang EJ; Yoo HE; Hong EK; Goh SH; Moon A; Lee JS; Ye SK; Shim J; Kim YN
Cancer Lett; 2021 Jun; 508():59-72. PubMed ID: 33771684
[TBL] [Abstract][Full Text] [Related]
27. The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.
Ng TL; Leprivier G; Robertson MD; Chow C; Martin MJ; Laderoute KR; Davicioni E; Triche TJ; Sorensen PH
Cell Death Differ; 2012 Mar; 19(3):501-10. PubMed ID: 21941369
[TBL] [Abstract][Full Text] [Related]
28. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
29. 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.
Shan C; Lu Z; Li Z; Sheng H; Fan J; Qi Q; Liu S; Zhang S
Cell Death Dis; 2019 Jul; 10(7):525. PubMed ID: 31285420
[TBL] [Abstract][Full Text] [Related]
30. The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.
Rodón L; Svensson RU; Wiater E; Chun MGH; Tsai WW; Eichner LJ; Shaw RJ; Montminy M
Sci Adv; 2019 Jul; 5(7):eaaw6455. PubMed ID: 31355336
[TBL] [Abstract][Full Text] [Related]
31. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
32. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
Zeng J; Liu W; Fan YZ; He DL; Li L
Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
[No Abstract] [Full Text] [Related]
33. Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.
Han JH; Kim YK; Kim H; Lee J; Oh MJ; Kim SB; Kim M; Kim KH; Yoon HJ; Lee MS; Minna JD; White MA; Kim HS
Cancer Commun (Lond); 2022 Aug; 42(8):716-749. PubMed ID: 35838183
[TBL] [Abstract][Full Text] [Related]
34. Spatial control of AMPK signaling at subcellular compartments.
Chauhan AS; Zhuang L; Gan B
Crit Rev Biochem Mol Biol; 2020 Feb; 55(1):17-32. PubMed ID: 32069425
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells.
Hindupur SK; Balaji SA; Saxena M; Pandey S; Sravan GS; Heda N; Kumar MV; Mukherjee G; Dey D; Rangarajan A
Breast Cancer Res; 2014 Aug; 16(4):420. PubMed ID: 25096718
[TBL] [Abstract][Full Text] [Related]
36. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.
Zhu XN; He P; Zhang L; Yang S; Zhang HL; Zhu D; Liu MD; Yu Y
Cell Death Dis; 2019 Jun; 10(7):486. PubMed ID: 31217475
[TBL] [Abstract][Full Text] [Related]
37. An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential.
Goodwin JM; Svensson RU; Lou HJ; Winslow MM; Turk BE; Shaw RJ
Mol Cell; 2014 Aug; 55(3):436-50. PubMed ID: 25042806
[TBL] [Abstract][Full Text] [Related]
38. Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio.
Wang Y; Wang B; Guerram M; Sun L; Shi W; Tian C; Zhu X; Jiang Z; Zhang L
Oncotarget; 2015 Oct; 6(30):29497-512. PubMed ID: 26470595
[TBL] [Abstract][Full Text] [Related]
39. AMP-activated protein kinase negatively regulates FcεRI-mediated mast cell signaling and anaphylaxis in mice.
Hwang SL; Li X; Lu Y; Jin Y; Jeong YT; Kim YD; Lee IK; Taketomi Y; Sato H; Cho YS; Murakami M; Chang HW
J Allergy Clin Immunol; 2013 Sep; 132(3):729-736.e12. PubMed ID: 23587332
[TBL] [Abstract][Full Text] [Related]
40. Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma.
Park IJ; Yang WK; Nam SH; Hong J; Yang KR; Kim J; Kim SS; Choe W; Kang I; Ha J
Apoptosis; 2014 Apr; 19(4):615-28. PubMed ID: 24173372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
